Browsing Centre for Clinical Pharmacology by Subject "Neointima"
Now showing items 1-4 of 4
-
Cezanne is a critical regulator of pathological arterial remodelling by targeting β-catenin signalling.
(Oxford University Press, 2021-02-18)AIM: Pathological arterial remodelling including neointimal hyperplasia and atherosclerosis is the main underlying cause for occluding arterial diseases. Cezanne is a novel deubiquitinating enzyme, functioning as a NF-кB ... -
Neointima and neoatherosclerotic characteristics in bare metal and first- and second-generation drug-eluting stents in patients admitted with cardiovascular events attributed to stent failure: an optical coherence tomography study.
(2018-02-02)AIMS: The aim of this study was to assess neoatherosclerotic plaque morphology in bare metal (BMS) and first- and second-generation drug-eluting stents (DES) in patients presenting with an event attributed to stent failure. ...